Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/23/2010US20100240747 Motuporamine Mimic Agents
09/23/2010US20100240746 Stereoisomers of tricyclodecan-9-yl-xanthogenate
09/23/2010US20100240745 Method of treatment of inflammation in hypertensive patients
09/23/2010US20100240744 Methods for the treatment of dementia based on apo e genotype
09/23/2010US20100240743 Cannabinoid receptor modulator
09/23/2010US20100240742 Anti-angiogenic compositions and methods of use
09/23/2010US20100240741 Pharmaceutical compositions for the administration of aptamers
09/23/2010US20100240738 Antisense modulation of kinesin-like 1 expression
09/23/2010US20100240737 Enzyme-prodrug therapy for prosthetic joint repair
09/23/2010US20100240736 Novel Compounds for the Treatment or Alleviation of Edema, and Methods for their Use
09/23/2010US20100240735 Pharmaceutical Compositions for Angiogenic Therapy
09/23/2010US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/23/2010US20100240733 Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1
09/23/2010US20100240732 Aptamer-targeted sirna to prevent attenuation or suppression of a t cell function
09/23/2010US20100240731 Lipopeptides for delivery of nucleic acids
09/23/2010US20100240730 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
09/23/2010US20100240728 Co-Crystals of Pyrrolidinones
09/23/2010US20100240727 Model for Glutamate Racemase Inhibitors and Glutamate Racemase Antibacterial Agents
09/23/2010US20100240726 Compositions for treating amyloid associated diseases
09/23/2010US20100240725 Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
09/23/2010US20100240724 Edible Film
09/23/2010US20100240723 Methods of treating cell proliferative disorders using a compressed temozolomide dosing schedule
09/23/2010US20100240721 desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; stabilizing microtubules
09/23/2010US20100240720 Allosteric jnk inhibitors
09/23/2010US20100240719 Novel alpha-(n-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
09/23/2010US20100240718 Novel heteroaryl-substituted acetone derivative, suitable for inhibiting phospholipase a2
09/23/2010US20100240717 Novel thiophene derivatives as s1p1/edg1 receptor agonists
09/23/2010US20100240716 Thiadiazoline derivative
09/23/2010US20100240715 Apoptosis promoters
09/23/2010US20100240714 Oral composition for dental purposes
09/23/2010US20100240713 Aromatic and heteroaromatic compounds useful in treating iron disorders
09/23/2010US20100240711 Solid preparation comprising npyy5 receptor antagonist
09/23/2010US20100240710 Use of Pyridoxamine to Treat and/or Prevent Disease Processes
09/23/2010US20100240709 Sulfoximine Derivatives as p38 MAP Kinase Inhibitors
09/23/2010US20100240708 Alpha-(N-Benzenesulfonamido)Cycloalkyl Derivatives
09/23/2010US20100240707 1,3,5-trisubstituted triazole derivative
09/23/2010US20100240706 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
09/23/2010US20100240704 Method of modulating stress-activated protein kinase system
09/23/2010US20100240703 Oxyimino compounds and the use thereof
09/23/2010US20100240702 Benzimidazolone Chymase Inhibitors
09/23/2010US20100240701 Tubulysins and processes for preparing
09/23/2010US20100240700 Prophylactic pretreatment with antioxidants
09/23/2010US20100240699 Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists
09/23/2010US20100240698 Macrocyclic inhibitors of hepatitis c virus
09/23/2010US20100240697 Pharmaceutical composition for treating overactive bladder
09/23/2010US20100240696 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
09/23/2010US20100240695 Stabilized zolpidem pharmaceutical compositions
09/23/2010US20100240694 Salt of naphthyridine carboxylic acid derivative
09/23/2010US20100240693 Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods
09/23/2010US20100240692 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
09/23/2010US20100240691 Morphinan derivatives with high oral bioavailability
09/23/2010US20100240690 Compositions containing opioid antagonists
09/23/2010US20100240689 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof
09/23/2010US20100240688 1,3-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1 h-1,4 bipyridinyl-2-ones
09/23/2010US20100240687 Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism
09/23/2010US20100240686 Chemical compounds
09/23/2010US20100240685 2-S-Benzyl Substituted Pyrimidines As CRTH2 Antagonists
09/23/2010US20100240684 Minoxidil aqueous composition containing bile acid
09/23/2010US20100240683 Combination therapy, composition and methods for the treatment of cardiovascular disorders
09/23/2010US20100240682 Phophylactic or therapeutic agent for inflamatory disease comprising thymidine phosphorylase inhibitor as active ingredient
09/23/2010US20100240681 Valomaciclovir polymorphs
09/23/2010US20100240680 Purine derivatives as a2a agonists
09/23/2010US20100240679 4-Phenylpiperidine Derivatives as Renin Inhibitors
09/23/2010US20100240678 Leukotriene b4 inhibitors
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240676 Thiazole derivatives
09/23/2010US20100240675 Therapeutic agents useful for treating pain
09/23/2010US20100240674 Use of compounds derived from benzamidine methanesulphonate or a pharmaceutically acceptable salt thereof, for example imatinib mesylate, for the preparation o f a drug for the treatment of neurodegenerative niemann-pick c disease (npc)
09/23/2010US20100240673 EML4-ALK Fusion Gene
09/23/2010US20100240672 Melt-processed imatinib dosage form
09/23/2010US20100240671 Substituted heterocyclic compounds
09/23/2010US20100240670 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application
09/23/2010US20100240669 New compounds
09/23/2010US20100240668 Myosin Light Chain Kinase Inhibitor Compounds, Compositions and Related Methods of Use
09/23/2010US20100240667 Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride
09/23/2010US20100240666 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
09/23/2010US20100240665 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
09/23/2010US20100240664 Solubilized topoisomerase poison agents
09/23/2010US20100240663 Heterocycles as potassium channel modulators
09/23/2010US20100240662 Reverse-turn mimetics and method relating thereto
09/23/2010US20100240661 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
09/23/2010US20100240660 New histone deacetylases inhibitors
09/23/2010US20100240659 Nitrogen-containing heterocyclic derivative having 11ss-hydroxysteroid dehydrogenase type i inhibitory activity
09/23/2010US20100240658 Oxadiazole Derivatives
09/23/2010US20100240657 Chemical compounds
09/23/2010US20100240656 Compounds as hsp90 inhibitors
09/23/2010US20100240655 Bromo-phenyl substituted thiazolyl dihydropyrimidines
09/23/2010US20100240654 Hydrazide derivatives
09/23/2010US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
09/23/2010US20100240652 Pyridine Derivatives as Sodium Channel Modulators
09/23/2010US20100240651 Water-soluble thalidomide derivatives
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240649 Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors
09/23/2010US20100240648 Hexahydro-pyrrolo-isoquinoline compounds
09/23/2010US20100240647 Treatment of Alzheimer's Disease and Related Conditions
09/23/2010US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
09/23/2010US20100240645 Combination of checkponit kinase (chk) and telangiectasia mutated (atm) inhibitors for the treatment of cancer
09/23/2010US20100240644 Morpholine derivative
09/23/2010US20100240642 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators
09/23/2010US20100240641 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors
1 ... 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 ... 7860